• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

目前公认的严重肢体缺血的血流动力学标准并不能准确地对有肢体丧失高风险的患者进行分层。

Current accepted hemodynamic criteria for critical limb ischemia do not accurately stratify patients at high risk for limb loss.

作者信息

Vallabhaneni Raghuveer, Kalbaugh Corey A, Kouri Ana, Farber Mark A, Marston William A

机构信息

Division of Vascular Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC.

Division of Vascular Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC; Department of Epidemiology, University of North Carolina Gillings School of Public Health, Chapel Hill, NC.

出版信息

J Vasc Surg. 2016 Jan;63(1):105-12. doi: 10.1016/j.jvs.2015.07.095. Epub 2015 Sep 26.

DOI:10.1016/j.jvs.2015.07.095
PMID:26412436
Abstract

OBJECTIVE

Critical limb ischemia (CLI) has been defined as rest pain or tissue loss in patients who have an ankle-brachial index (ABI) ≤0.50, ankle pressure (AP) <70 mm Hg, or toe pressure (TP) <50 mm Hg. Data suggesting that these patients are at high risk for limb loss without successful revascularization are limited. This study was designed to identify limb loss and mortality rates in patients who did not respond to revascularization or who were not revascularized to determine whether CLI hemodynamic criteria accurately identify patients at high risk for limb loss.

METHODS

Between 2008 and 2010, all patients undergoing lower extremity arterial duplex ultrasound testing at our hospital were identified. Those with ABI <0.50, AP <70 mm Hg, or TP <50 mm Hg were retrospectively reviewed to determine whether they had symptoms of rest pain, ischemic ulceration, or gangrene qualifying them for analysis in the database. Patients who underwent revascularization and subsequently had postrevascularization ABI, AP, or TP greater than the CLI criteria were removed from the cohort. Demographic factors, wound healing, amputation rates, and mortality were obtained and analyzed in relation to the initial APs and TPs. Outcomes were measured by Kaplan-Meier life-table analysis and Cox proportional hazards models.

RESULTS

In 381 patients identified in the study, 443 limbs met CLI criteria. After revascularization, 98 limbs with ABI or TP that improved to >0.5 and >50 mm Hg, respectively, were removed from the study cohort. In 45 limbs, patients did not respond to initial revascularization as their ABI, AP, or TP remained within CLI criteria. These limbs remained in the patient cohort, yielding a final group of 296 patients and 345 limbs. Mean follow-up was 2 years. In the entire patient cohort, limb loss occurred in 24% at 1 year and in 31% at 3 years. Mortality was 32% at 1 year and 56% at 3 years. Amputation-free survival was 54% at 1 year and 28% at 3 years. Lower TPs were associated with a statistically higher incidence of amputation. Among those with an initial TP ≤10 mm Hg (n = 85), limb loss occurred in 46% at 1 year and 60% at 3 years. This limb loss was significantly greater than limb loss among those with a TP of 31 to 50 mm Hg (n = 115; 18% at 3 years; P < .001) Amputation-free survival in patients with a TP ≤10 mm Hg was 8% at 3 years.

CONCLUSIONS

CLI is associated with a high mortality, but not all patients with currently defined hemodynamic criteria for CLI are at high risk of limb loss. Patients with a TP between 31 and 50 mm Hg (41% of the cohort) and not receiving revascularization or not responding hemodynamically to revascularization experienced a low risk of limb loss. We recommend revising the hemodynamic criteria for CLI to better identify patients at high risk for limb loss who require intervention to improve outcomes.

摘要

目的

严重肢体缺血(CLI)被定义为踝肱指数(ABI)≤0.50、踝压(AP)<70 mmHg或趾压(TP)<50 mmHg的患者出现静息痛或组织缺失。关于这些患者在未成功进行血运重建的情况下肢体丧失风险很高的数据有限。本研究旨在确定对血运重建无反应或未接受血运重建的患者的肢体丧失和死亡率,以确定CLI血流动力学标准是否能准确识别肢体丧失高风险患者。

方法

在2008年至2010年期间,识别出我院所有接受下肢动脉双功超声检查的患者。对ABI<0.50、AP<70 mmHg或TP<50 mmHg的患者进行回顾性分析,以确定他们是否有静息痛、缺血性溃疡或坏疽症状,从而有资格纳入数据库分析。接受血运重建且术后ABI、AP或TP大于CLI标准的患者被排除在队列之外。获取并分析人口统计学因素、伤口愈合情况、截肢率和死亡率与初始AP和TP的关系。通过Kaplan-Meier生存表分析和Cox比例风险模型测量结果。

结果

在本研究中识别出的381例患者中,443条肢体符合CLI标准。血运重建后,98条ABI或TP分别改善至>0.5和>50 mmHg的肢体被排除在研究队列之外。在45条肢体中,患者对初始血运重建无反应,因为他们的ABI、AP或TP仍在CLI标准范围内。这些肢体仍留在患者队列中,最终形成了296例患者和345条肢体的组。平均随访时间为2年。在整个患者队列中,1年时肢体丧失发生率为24%,3年时为31%。1年时死亡率为32%,3年时为56%。无截肢生存率1年时为54%,3年时为28%。较低的TP与截肢发生率在统计学上的显著升高相关。在初始TP≤10 mmHg的患者(n = 85)中,1年时肢体丧失发生率为46%,3年时为60%。这种肢体丧失明显高于TP为31至50 mmHg的患者(n = 115;3年时为18%;P <.001)。TP≤10 mmHg的患者3年时无截肢生存率为8%。

结论

CLI与高死亡率相关,但并非所有目前定义的CLI血流动力学标准患者都有高肢体丧失风险。TP在31至50 mmHg之间(占队列的41%)且未接受血运重建或对血运重建无血流动力学反应的患者,肢体丧失风险较低。我们建议修订CLI的血流动力学标准,以更好地识别需要干预以改善预后的肢体丧失高风险患者。

相似文献

1
Current accepted hemodynamic criteria for critical limb ischemia do not accurately stratify patients at high risk for limb loss.目前公认的严重肢体缺血的血流动力学标准并不能准确地对有肢体丧失高风险的患者进行分层。
J Vasc Surg. 2016 Jan;63(1):105-12. doi: 10.1016/j.jvs.2015.07.095. Epub 2015 Sep 26.
2
Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system following infrapopliteal endovascular interventions for critical limb ischemia.血管外科学会伤口、缺血和足部感染(WIfI)分类系统对严重肢体缺血患者腘下血管腔内介入治疗后的预测能力。
J Vasc Surg. 2016 Sep;64(3):616-22. doi: 10.1016/j.jvs.2016.03.417. Epub 2016 Jul 2.
3
Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus.糖尿病患者和非糖尿病患者下肢血管腔内血运重建后的主要肢体结局
J Endovasc Ther. 2017 Jun;24(3):376-382. doi: 10.1177/1526602817705135. Epub 2017 Apr 25.
4
Amputation-free Survival in Patients with Critical Limb Ischemia Treated with Paclitaxel-eluting Stents and Paclitaxel-coated Balloons.使用紫杉醇洗脱支架和紫杉醇涂层球囊治疗的严重肢体缺血患者的无截肢生存期
Ann Vasc Surg. 2020 Jan;62:8-14. doi: 10.1016/j.avsg.2019.05.013. Epub 2019 Jun 15.
5
Society for Vascular Surgery Wound, Ischemia, foot Infection (WIfI) score correlates with the intensity of multimodal limb treatment and patient-centered outcomes in patients with threatened limbs managed in a limb preservation center.血管外科学会伤口、缺血、足部感染(WIfI)评分与在肢体保全中心接受治疗的肢体威胁患者的多模式肢体治疗强度及以患者为中心的预后相关。
J Vasc Surg. 2017 Aug;66(2):488-498.e2. doi: 10.1016/j.jvs.2017.01.063. Epub 2017 Apr 11.
6
Impact of endovascular options on lower extremity revascularization in young patients.腔内治疗方案对年轻患者下肢血运重建的影响。
J Vasc Surg. 2012 Sep;56(3):703-13.e1-3. doi: 10.1016/j.jvs.2012.01.073. Epub 2012 May 10.
7
Hemodynamic Assessment Before and After Endovascular Therapy for Critical Limb Ischemia and Association With Clinical Outcomes.血管内治疗对严重肢体缺血前后的血液动力学评估及其与临床结局的关系。
JACC Cardiovasc Interv. 2017 Dec 11;10(23):2451-2457. doi: 10.1016/j.jcin.2017.06.063. Epub 2017 Nov 15.
8
Endovascular-First Treatment Is Associated With Improved Amputation-Free Survival in Patients With Critical Limb Ischemia.对于严重肢体缺血患者,血管内优先治疗与无截肢生存率的提高相关。
Circ Cardiovasc Qual Outcomes. 2019 Aug;12(8):e005273. doi: 10.1161/CIRCOUTCOMES.118.005273. Epub 2019 Jul 30.
9
Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions.基于血管生成概念的直接和间接血管内血运重建治疗伴有孤立膝下病变的临界肢体缺血患者的长期结果。
J Vasc Surg. 2012 Feb;55(2):363-370.e5. doi: 10.1016/j.jvs.2011.08.014. Epub 2011 Nov 1.
10
Clinical results of single-vessel versus multiple-vessel infrapopliteal intervention.单支与多支腘下血管介入治疗的临床结果
J Vasc Surg. 2016 Dec;64(6):1675-1681. doi: 10.1016/j.jvs.2016.05.080. Epub 2016 Aug 31.

引用本文的文献

1
Effects of L-Ornithine-L-Aspartate on Angiogenesis and Perfusion in Subacute Hind Limb Ischemia: Preliminary Study.L-鸟氨酸-L-天冬氨酸对亚急性后肢缺血血管生成和灌注的影响:初步研究
Biomedicines. 2024 Aug 6;12(8):1787. doi: 10.3390/biomedicines12081787.
2
Angiosome-Targeted Infrapopliteal Angioplasty: Impact on Clinical Outcomes-An Observational Study.血管体靶向腘下血管成形术:对临床结局的影响——一项观察性研究
J Clin Med. 2024 Feb 2;13(3):883. doi: 10.3390/jcm13030883.
3
Tibio-pedal arterial pressure assessment during endovascular intervention to improve quality-of-life in patients with intermittent claudication.
血管内介入治疗期间评估胫-足动脉压以改善间歇性跛行患者的生活质量。
Front Cardiovasc Med. 2022 Nov 29;9:1038353. doi: 10.3389/fcvm.2022.1038353. eCollection 2022.
4
Analysis of wound healing time and wound-free period in patients with chronic limb-threatening ischemia treated with and without revascularization.分析有/无血运重建治疗的慢性肢体严重缺血患者的伤口愈合时间和无伤口期。
J Vasc Surg. 2022 Dec;76(6):1667-1673.e1. doi: 10.1016/j.jvs.2022.05.025. Epub 2022 Jul 8.
5
Interventional- and amputation-stage muscle proteomes in the chronically threatened ischemic limb.慢性缺血肢体的干预和截肢阶段肌肉蛋白质组学。
Clin Transl Med. 2022 Jan;12(1):e658. doi: 10.1002/ctm2.658.
6
Toe pressure and toe brachial index are predictive of cardiovascular mortality regardless of the most diseased arterial segment in symptomatic lower-extremity artery disease-A retrospective cohort study.无论在有症状的下肢动脉疾病中最严重病变的动脉节段如何,足压和足臂指数均可预测心血管死亡率:一项回顾性队列研究。
PLoS One. 2021 Nov 15;16(11):e0259122. doi: 10.1371/journal.pone.0259122. eCollection 2021.
7
PredyCLU: A prediction system for chronic leg ulcers based on fuzzy logic; part II-Exploring the arterial side.PredyCLU:基于模糊逻辑的慢性腿部溃疡预测系统;第二部分-探索动脉侧。
Int Wound J. 2020 Aug;17(4):987-991. doi: 10.1111/iwj.13360. Epub 2020 Apr 13.
8
Impact of diabetes on outcome in critical limb ischemia with tissue loss: a large-scaled routine data analysis.糖尿病对伴有组织缺损的严重肢体缺血患者预后的影响:一项大规模常规数据分析
Cardiovasc Diabetol. 2017 Apr 4;16(1):41. doi: 10.1186/s12933-017-0524-8.
9
Dynamic imaging of allogeneic adipose-derived regenerative cells transplanted in ischemic hind limb of apolipoprotein E mouse model.载脂蛋白E小鼠模型缺血后肢中移植的同种异体脂肪来源再生细胞的动态成像
Int J Nanomedicine. 2016 Dec 21;12:61-71. doi: 10.2147/IJN.S118328. eCollection 2017.